John Oyler

About John Oyler

John Oyler is the CEO and cofounder of biotech outfit BeiGene. He owns about 5% of the publicly traded company.

BeiGene, which was founded in 2010 as a research and development firm, went public on the Nasdaq in 2016 and listed in Hong Kong two years later.

Before he cofounded BeiGene, Oyler helped start and then sell two companies in the U.S. and China.

He sold Telephia, a consumer telecom research firm he founded in 1997, to The Nielsen Co. for $449 million in 2007.

Oyler's next success came with drug discovery outsourcing company BioDuro, which he founded in 2005 and sold to PPD Inc. for $77 million in 2010.